SUMMARY
We have used multilocus analysis to exclude the cystic fibrosis locus from six polymorphic DNA markers covering most of chromosome 19. A substantial increase in the confidence for exclusion was obtained using the computer programme LINKAGE compared to analysis of pairwise lod scores. A structured approach to the analysis of linkage to autosomal recessive inherited diseases where the biochemical defect is not known is described.
Cystic fibrosis (CF) is the most common genetic disease in North European populations, with an incidence of 1 in 2000 live births in the United Kingdom. The biochemical basis of the mutation in CF is not known, although membrane transport phenomena associated with the disease have recently been described. ' 2 Evidence from segregation analyses has confirmed that the inheritance of CF is consistent with its being a recessive defect caused by a mutation at a single autosomal locus. 3 The use of DNA probes for the analysis of genetic disease allows the determination of linkage between a restriction fragment length polymorphism (RFLP) and a disease locus even when the biochemical defect is unknown. This approach has already been used successfully by us to analyse sex linked genetic diseases such as Duchenne muscular dystrophy,4 as well as to study previously unassigned autosomal dominant diseases such as Huntington's disease.5
There were, until recently, few clues as to the chromosomal localisation of the CF locus (CF). Mayo et al6 suggested that CF might be located on chromosome 4, based on data from cell hybrids expressing a ciliary dyskinesis factor. We have shown that the mutation causing CF is unlikely to be on chromosome 4 
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GENE PROBES LOCATED ON CHROMOSOME 19
The cloned DNA sequences used in this study are listed in table 1 together with regional assignments of the markers and details of the RFLP defined by 
APOC2-CYP-J-D19S6
). An estimate of the total 
